RightAnswer Knowledge Solutions Search Results for Propylthiouracil

New Search  |  Search Results (Propylthiouracil)  |  Index of Example Chemical Results Pages
register now
RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.

A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
  • Chemical Identification
  • Environmental Hazards
  • First Aid/Medical Treatment
  • Handling/Storage/Shipping/Waste Management
  • MSDS Documents
  • Personal Protection
  • Physical Hazards/Corrective Response Actions
  • Physical/Chemical Properties
  • Regulatory/Standards/Labels
  • Report Abstracts and Studies
  • Reproductive Risk
  • Toxicology/Health Hazards/Exposure
Example of Acute Exposure data from MEDITEXT.

RightAnswer Proprietary Data Sources:

HAZARDTEXT™ Documentshelp
MEDITEXT® Documentshelp
REPROTEXT® Documentshelp

All Other Data Sources:

CCRIS Documentshelp
DART Documentshelp
• [Thyroid dysfunction and pregnancy]
• A comparison of PTU versus tapazole in the treatment of hyperthyroidism.
• A developmental neurotoxicity study of propylthiouracil in rats.
Show More
ECOTOX Documentshelp
Fisher MSDShelp
GENE-TOX Documentshelp
HSDB® Data Bankhelp
LOLI® Listingshelp
NTP - Reproductive Toxicology Study Abstractshelp
REPROTOX® Documentshelp
RTECS® Registryhelp
Shepard's Cataloghelp
TERIS Documentshelp

ChemID External Links:

Other Government Links Searched via RegsKnowledge:

State Environmental Regulationshelp
CFR Regulationshelp

Example Content from MEDITEXT for Propylthiouracil:

Please note: this is an extract of information from a larger document. Full document and details are available by subscription.


    1. ADVERSE EFFECTS: Chronic therapeutic ingestion can result in a variety of immunologic-mediated adverse effects which are not expected to occur in overdose, including leukopenia, agranulocytosis, aplastic anemia, eosinophilia, leukopenia, thrombocytopenia, vasculitis and hypoprothrombinemia. In addition, chronic ingestion of propylthiouracil have produced a characteristic hepatocellular or mixed cytotoxic-cholestatic hepatitis, believed to be a hypersensitivity reaction. Transaminase levels are typically elevated, with or without elevated bilirubin and alkaline phosphatase. The onset of symptoms is 2 weeks to 5 months after initiation of therapy. Rare reports of hepatitis, hepatic necrosis, encephalopathy have occurred; some cases have been fatal. Skin rashes may occur secondary to hematologic toxicity during chronic therapy. Cutaneous hypersensitivity vasculitis is an immune-mediated adverse reaction to propylthiouracil. Arthritis as well as polymyositis, synovitis, arthralgias, and an SLE-like syndrome, exertional dyspnea, hypoxemia, cough, and productive sputum may be observed with therapeutic use. Hypocalcemia, eosinophilia, nephritis have also been reported with therapeutic use.
    1. OVERDOSE: Very little data are available on the effects of acute overdose. Decreased T3 and elevated alkaline phosphatase levels were the only effects seen after a massive overdose in a 12-year-old girl.
© 2011-2021 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.